Reporting and representation of race/ethnicity in published randomized trials

American Heart Journal

Volumn 158, Issue 5, 2009, Pages 742-747

  Berger, Jeffrey S ^a,b   Melloni, Chiara ^b   Wang, Tracy Y ^b   Dolor, Rowena J ^b   Frazier, Camille G ^b   Samad, Zainab ^b   Peterson, Eric D ^b   Mark, Daniel B ^b   Newby, L Kristin ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AFRICAN AMERICAN; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CAUCASIAN; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DEMOGRAPHY; ETHNICITY; HISPANIC; HUMAN; INFORMATION PROCESSING; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; PATIENT SELECTION; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 70350077251     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.08.018     Document Type: Article

References (22)

1. Ferdinand K.C. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 97 (2006) 12A-19A
2. Kressin N.R., and Petersen L.A. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 135 (2001) 352-366
3. Sonel A.F., Good C.B., Mulgund J., et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 111 (2005) 1225-1232
4. Fincher C., Williams J.E., MacLean V., et al. Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethn Dis 14 (2004) 360-371
5. Nasir K., Shaw L.J., Liu S.T., et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol 50 (2007) 953-960
6. Peterson E.D., Wright S.M., Daley J., et al. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA 271 (1994) 1175-1180
7. US Food and Drug Administration. Guideline for the Study of Drugs Likely to Be Used in the Elderly (1989), Food and Drug Administration/Center for Drug Evaluation and Research, Rockville (Md)
8. National Institutes of Health guidelines on the inclusion of women and minorities as subjects in clinical research, 59 Federal Register. 11146 (1994). Available at: http//grants.nih.gov/grants/guide/notice-files/not94-100.html. Accessed September 15, 2009.
9. U.S. Congress Public Law 103-43: National Institutes of Health Revitalization Act of 1993; 1993 [Washington, DC]. Available at: http://grants.nih.gov/grants/guides/rfa-files/RFA-HS-95-004.html. Accessed September 15, 2009.
10. Buring J.E. Women in clinical trials-a portfolio for success. N Engl J Med 343 (2000) 505-506
11. Harris D.J., and Douglas P.S. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 343 (2000) 475-480
12. Lee P.Y., Alexander K.P., Hammill B.G., et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286 (2001) 708-713
13. Hutchins L.F., Unger J.M., Crowley J.J., et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341 (1999) 2061-2067
14. Murthy V.H., Krumholz H.M., and Gross C.P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291 (2004) 2720-2726
15. Djomand G., Katzman J., di Tommaso D., et al. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Public Health Rep 120 (2005) 543-548
16. Mosca L., Banka C.L., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115 (2007) 1481-1501
17. Kaplan J.B., and Bennett T. Use of race and ethnicity in biomedical publication. JAMA 289 (2003) 2709-2716
18. Protocol Registration System and U.S. Public Law 110-85. Available at:. http://prsinfo.clinicaltrials.gov/fdaaa.html Accessed August 20, 2009
19. Tse T., Williams R.J., and Zarin D.A. Reporting "basic results" in ClinicalTrials.gov. Chest 136 (2009) 295-303
20. Yasuda S.U., Zhang L., and Huang S.M. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther 84 (2008) 417-423
21. McDowell S.E., Coleman J.J., and Ferner R.E. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 332 (2006) 1177-1181
22. Berger JS, Bairey-Merz CN, Redberg RF, et al. Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. Am Heart J 2008;156:816-825, 825 e811.